Sanjeev Deshpande | Pharmaceutical Science | Academic Excellence in Innovation Award

Posted-on by Indian Scientist Awards

Academic Excellence in Innovation Award

Sanjeev Deshpande
Dr. D. Y. Patil College of Pharmacy, Akurdi, India

Sanjeev Deshpande
Affiliation Dr. D. Y. Patil College of Pharmacy, Akurdi
Country India
Google Scholar ID Zlnn4BcAAAAJ
Citations 218
h-index 9
i10-index 10
Subject Area Pharmaceutical Sciences and Phytochemistry
Event Indian Scientist Awards

Sanjeev Deshpande is presented in the supplied researcher profile as affiliated with Dr. D. Y. Patil College of Pharmacy, Akurdi, India, with research interests identified as pharmaceutical sciences and phytochemistry. The provided Google Scholar metrics report 218 citations, an h-index of 9, and an i10-index of 10. These indicators offer a preliminary overview of scholarly visibility for consideration in the Academic Excellence in Innovation Award category at Indian Scientist Awards. [1] [2]

Abstract

This article presents the supplied academic profile of Sanjeev Deshpande, affiliated with Dr. D. Y. Patil College of Pharmacy, Akurdi, India. His stated subject areas are pharmaceutical sciences and phytochemistry. The provided Google Scholar profile reports 218 citations, an h-index of 9, and an i10-index of 10. These indicators summarize aspects of citation-based visibility but do not independently establish research originality or innovation. A comprehensive assessment should examine verified publications, scientific methods, and documented contributions before evaluating award suitability. [1] [2]

Keywords

Sanjeev Deshpande; Academic Excellence in Innovation Award; Indian Scientist Awards; pharmaceutical sciences; phytochemistry; pharmaceutical research; natural products; scholarly publications; citation analysis; research innovation; academic impact. [1]

Introduction

Pharmaceutical sciences integrate drug discovery, formulation, analysis, pharmacology, and the evaluation of therapeutic substances. Phytochemistry investigates chemical compounds derived from plants and their potential biological properties. These fields contribute to pharmaceutical development and evidence-based investigation of natural products. Sanjeev Deshpande’s supplied profile identifies these subject areas within his academic background. His research achievements should be assessed through verified publications, documented methodologies, and evidence of scientific relevance. [2]

Research Profile

The supplied profile associates Sanjeev Deshpande with Dr. D. Y. Patil College of Pharmacy, Akurdi, India, and identifies pharmaceutical sciences and phytochemistry as his subject areas. His Google Scholar profile lists 218 citations, an h-index of 9, and an i10-index of 10. These metrics offer a preliminary view of scholarly visibility. The current profile and associated publications should be checked to confirm their accuracy and relevance. [1] [2]

Research Contributions

Research in pharmaceutical sciences and phytochemistry may involve identifying plant-derived compounds, characterizing chemical constituents, evaluating biological activity, and developing pharmaceutical formulations. Sanjeev Deshpande’s specific contributions should be established through verified research papers, experimental methods, and documented findings. Citation metrics alone cannot demonstrate particular discoveries or therapeutic benefits. A rigorous evaluation should consider methodological quality, reproducibility, originality, and the significance of each contribution to pharmaceutical research.[2]

Publications

The supplied Google Scholar profile provides a basis for locating publications associated with Sanjeev Deshpande. Each relevant paper should be verified for its title, authorship, publication venue, year, and digital object identifier where available. Reviewing the original articles can clarify research themes, analytical techniques, and the evidence supporting reported findings. Specific publications and DOI identifiers should be included only after bibliographic details have been independently confirmed. [1]

Research Impact

The supplied Google Scholar profile reports 218 citations, an h-index of 9, and an i10-index of 10. Citation counts reflect references received by indexed publications, while the h-index and i10-index summarize aspects of publication and citation activity. These indicators provide useful context but do not independently measure scientific quality, societal benefit, or practical innovation. Research impact should also consider reproducibility, independent validation, applications, and contributions to pharmaceutical knowledge. [1] [2]

Award Suitability

Sanjeev Deshpande’s reported citation indicators provide preliminary context for consideration under the Academic Excellence in Innovation Award category at Indian Scientist Awards. A balanced assessment should examine the nominated work’s originality, scientific validity, methodological rigor, practical relevance, and contribution to pharmaceutical sciences or phytochemistry. The researcher’s broader publication record may offer supporting evidence, but citation metrics alone cannot establish eligibility or guarantee recognition. Final consideration depends on verified achievements and the organizer’s published criteria. [2]

Conclusion

The supplied profile presents Sanjeev Deshpande as affiliated with Dr. D. Y. Patil College of Pharmacy, Akurdi, India, with stated interests in pharmaceutical sciences and phytochemistry. His reported 218 citations, h-index of 9, and i10-index of 10 provide a quantitative overview of scholarly visibility. A complete assessment of academic innovation should additionally verify publications and examine originality, research quality, reproducibility, and documented contributions before drawing conclusions about award suitability. [1]

References

  1. Google Scholar. (n.d.). Sanjeev Deshpande: Google Scholar profile. Researcher profile and citation indicators supplied for this article. The current record should be checked before publishing bibliometric information.
    https://scholar.google.com/citations?user=Zlnn4BcAAAAJ&hl=en
  2. Indian Scientist Awards. (n.d.). Official award website. The organizer’s website is the appropriate source for checking nomination procedures, award categories, eligibility requirements, deadlines, and evaluation criteria relevant to the Academic Excellence in Innovation Award.
    https://indianscientist.in/

Medhaa Bhattacharya | Healthcare Innovations and Medical Breakthroughs | Innovative Research Award

Posted-on by Indian Scientist Awards

Innovative Research Award

Medhaa Bhattacharya
Agartala Government Medical College & Govind Ballabh Pant Hospital, India

Medhaa Bhattacharya
Affiliation Agartala Government Medical College & Govind Ballabh Pant Hospital
Country India
Scopus ID 60572523400
Documents 2
Subject Area Gynae-oncology
Event Indian Scientist Awards

The Innovative Research Award highlights research engagement, scientific inquiry, and contributions to advancing knowledge. Medhaa Bhattacharya is associated with Agartala Government Medical College and Govind Ballabh Pant Hospital, India. The supplied academic profile identifies gynae-oncology as her subject area and lists two Scopus documents for scholarly reference and further evaluation. [1] [2]

Abstract

Medhaa Bhattacharya’s supplied academic profile identifies gynae-oncology as her subject area and Agartala Government Medical College and Govind Ballabh Pant Hospital as her institutional affiliation. The provided Scopus identifier lists two documents. Further review of individual publications, research methods, and clinical relevance is necessary to assess the scope and significance of her scholarly contributions. [1] [2]

Keywords

Medhaa Bhattacharya, Innovative Research Award, gynae-oncology, gynecologic oncology, women’s health, cancer research, clinical research, medical education, scientific publications, Indian Scientist Awards.

Introduction

Gynae-oncology focuses on cancers affecting the female reproductive system, combining clinical assessment, diagnosis, treatment, and ongoing research. Medhaa Bhattacharya is affiliated with Agartala Government Medical College and Govind Ballabh Pant Hospital in India. Her supplied research profile provides a starting point for documenting academic engagement in this specialized medical field. [1] [2]

Research Profile

Medhaa Bhattacharya’s supplied research profile connects her with gynae-oncology and a medical institution in Agartala, India. The provided Scopus author identifier is 60572523400, with two documents reported in the input information. Publication-level verification is needed to establish specific research topics, methods, collaborations, and clinical interests. [1]

Research Contributions

Research in gynae-oncology can support earlier diagnosis, improved treatment strategies, patient care, and understanding of cancers affecting the female reproductive system. Medhaa Bhattacharya’s specific contributions should be described through verified publications and documented research activities. Examining study design, findings, and clinical relevance can establish how her work contributes to the wider field. [1]

Publications

The supplied Scopus information lists two documents associated with the researcher identifier provided for Medhaa Bhattacharya. Individual publication titles, journal names, publication dates, and DOI identifiers should be confirmed against the author record before inclusion. Accurate bibliographic verification supports appropriate attribution and helps readers locate and evaluate the underlying research. [1]

Research Impact

Research impact in gynae-oncology may be assessed through scientific quality, citations, clinical relevance, and the potential to inform patient care or future investigations. The available input does not provide verified citation counts or an h-index for Medhaa Bhattacharya. Reviewing her publications and subsequent research citing them would enable a more balanced assessment. [1]

Award Suitability

Medhaa Bhattacharya’s stated institutional affiliation and research area provide relevant background for consideration under the Innovative Research Award. A comprehensive evaluation should consider originality, research quality, documented contributions, publication evidence, and compliance with official eligibility criteria. The available information alone does not establish nomination, selection, or receipt of an award from the Indian Scientist Awards. [1]

Conclusion

Medhaa Bhattacharya’s supplied academic details identify an affiliation with Agartala Government Medical College and Govind Ballabh Pant Hospital and a subject area in gynae-oncology. The reported Scopus record offers a starting point for documenting research activity. Verified publications and supporting evidence are necessary for evaluating scholarly contributions and award suitability. [1] [2]

References

  1. Elsevier. (n.d.). Scopus author details: Medhaa Bhattacharya, Author ID 60572523400. Scopus. The document count is reproduced from the supplied information and should be checked against the current author profile.
    https://www.scopus.com/authid/detail.uri?authorId=60572523400
  2. Indian Scientist Awards. (n.d.). Official award website. Consult the official website for current award categories, eligibility requirements, and submission procedures.
    https://indianscientist.in/

Tarannun Sayyad | Toxicology and Pharmaceutical Science | Academic Excellence in Innovation and Technology Award

Posted-on by Indian Scientist Awards

Academic Excellence in Innovation and Technology Award

Tarannun Sayyad
Shree Sureshdada Jain Institute of Pharmaceutical Education and Research, India

Tarannun Sayyad
Affiliation Shree Sureshdada Jain Institute of Pharmaceutical Education and Research
Country India
Google Scholar B9aSw94AAAAJ&hl=en
Subject Area Pharmacy
Event Indian Scientist Awards
ORCID 0009-0002-8673-0284

The Academic Excellence in Innovation and Technology Award recognizes the scholarly contributions of Tarannun Sayyad, whose academic profile in pharmacy reflects sustained engagement with research, professional education, and scientific knowledge dissemination through recognized research platforms and institutional affiliation. [1] [2]

Abstract

Tarannun Sayyad’s academic profile demonstrates engagement in pharmacy research through institutional affiliation, scholarly publications, and recognized research identifiers. The available academic records indicate participation in scientific communication and research dissemination, supporting professional development within pharmaceutical sciences and aligning with the objectives of academic recognition initiatives. [1] [2]

Keywords

Pharmacy, Pharmaceutical Research, Academic Excellence, Innovation, Scientific Publications, Research Profile, Indian Scientist Awards, ORCID, Google Scholar, Higher Education

Introduction

Tarannun Sayyad is associated with Shree Sureshdada Jain Institute of Pharmaceutical Education and Research, contributing to pharmacy through academic learning and research activities. Her scholarly presence is supported by recognized researcher identifiers, reflecting participation in scientific communication and knowledge sharing within pharmaceutical sciences. [1] [2]

Research Profile

Her research profile combines institutional affiliation with publicly accessible scholarly records, including Google Scholar and ORCID. These platforms document research visibility, publication activity, and professional identity, supporting transparent academic documentation and facilitating collaboration within the pharmacy research community. [1] [2]

Research Contributions

Her academic contributions emphasize pharmaceutical research, scientific documentation, and participation in scholarly dissemination. Available records indicate engagement with research outputs that support evidence-based learning while contributing to broader discussions within pharmacy and related biomedical fields through recognized academic platforms. [1] [2]

Publications

Her publications are indexed through Google Scholar, where research outputs are organized for academic visibility and citation tracking. These records provide a structured overview of scholarly work while supporting accessibility, research evaluation, and continued engagement with pharmaceutical research communities. [1] [2]

Research Impact

Her scholarly presence contributes to research visibility through recognized academic identifiers and accessible publication records. Such documentation supports citation tracking, professional networking, and the dissemination of pharmaceutical knowledge, strengthening opportunities for academic collaboration and continued research engagement. [1] [2]

Award Suitability

Her documented academic affiliation, research visibility, and participation in scholarly communication align with the principles of the Indian Scientist Awards. Publicly accessible academic profiles provide evidence of professional engagement, making her profile relevant for recognition within pharmacy-focused academic excellence initiatives. [1]

Conclusion

Tarannun Sayyad’s academic profile reflects sustained involvement in pharmacy education and scholarly communication through recognized research platforms. Her documented professional identity, institutional association, and accessible research records collectively support a credible foundation for academic recognition and continued contribution to pharmaceutical sciences. [1] [3]

References

  1. Google Scholar. (n.d.). Tarannun Sayyad – Google Scholar profile.
    https://scholar.google.com/citations?user=B9aSw94AAAAJ&hl=en
  2. ORCID. (n.d.). Tarannun Sayyad – ORCID: 0009-0002-8673-0284.
    https://orcid.org/0009-0002-8673-0284
  3. Indian Scientist Awards. (n.d.). Official Award Website.
    https://indianscientist.in/

jimmy Alexander | Chemistry | Young Scientist Award

Posted-on by Indian Scientist Awards

Young Scientist Award

Jimmy Alexander
MGM College of Pharmacy, Kannur, Kerala, India

Jimmy Alexander
Affiliation MGM College of Pharmacy, Kannur, Kerala
Country India
Google Scholar ID 7Z3vnIwAAAAJ&hl=en
Citations 8
h-index 2
Subject area Medicinal chemistry
Event Indian Scientist Awards

This article presents a research-oriented profile of Jimmy Alexander, affiliated with MGM College of Pharmacy in Kannur, Kerala, India, in the subject area of medicinal chemistry. It outlines the available researcher information, reported citation indicators, academic interests, and the context of a potential recognition associated with the Indian Scientist Awards. The details should be evaluated against verifiable academic records before being used to establish award eligibility or confirmed recognition. [1] [2]

Abstract

This profile summarizes the supplied academic information for Jimmy Alexander, whose stated institutional affiliation is MGM College of Pharmacy, Kannur, Kerala, India, and whose subject area is medicinal chemistry. The reported Google Scholar metrics are eight citations and an h-index of two. These indicators offer limited information about research visibility and should be interpreted alongside verified publications, research quality, and documented scholarly contributions. No award outcome is asserted here. [1] [2]

Keywords

Jimmy Alexander; medicinal chemistry; pharmaceutical sciences; academic research; Google Scholar; research publications; citation analysis; h-index; MGM College of Pharmacy; Indian Scientist Awards. These keywords describe the supplied profile and its research context rather than independently verified research specializations or confirmed award status. [1]

 Introduction

Medicinal chemistry connects chemical sciences with drug discovery, molecular design, and the investigation of biologically active compounds. Jimmy Alexander is identified in the supplied information as a researcher affiliated with MGM College of Pharmacy, Kannur, Kerala, India. This profile organizes the available academic details and outlines considerations relevant to evaluating research activity and potential scientific recognition. [1]

Research Profile

Jimmy Alexander is associated, according to the provided details, with MGM College of Pharmacy in Kannur, Kerala. Medicinal chemistry is the stated subject area, although specific projects, methods, and research themes require confirmation from publications or institutional records. The supplied Google Scholar profile provides a starting point for reviewing indexed scholarly work and reported citation indicators. [1] [2]

 Research Contributions

Research contributions in medicinal chemistry may include compound design, synthesis, characterization, computational screening, biological evaluation, and interpretation of structure–activity relationships. However, individual contributions by Jimmy Alexander cannot be established from citation metrics or affiliation alone. Specific achievements should be described using verified papers, documented research responsibilities, reproducible findings, and evidence of scientific collaboration or application. [2]

 Publications

A complete publication list is necessary to assess the research record of Jimmy Alexander. The supplied Google Scholar profile can be consulted to identify potentially relevant articles, author collaborations, publication dates, and citation counts. Each record should be checked against its publisher page, bibliographic metadata, and DOI where available. No specific publication titles or DOI identifiers are asserted here without verification. [1] [2]

Research Impact

The supplied profile reports eight citations and an h-index of two for Jimmy Alexander. These indicators provide a limited quantitative snapshot of scholarly attention and may change as publications are indexed and cited. They do not independently establish methodological quality, originality, societal benefit, or clinical significance. A balanced assessment should consider publication quality, field context, collaboration, reproducibility, and documented research outcomes. [1]

 Award Suitability

Potential suitability for the Indian Scientist Awards should be evaluated against the organizer’s published eligibility criteria, award categories, nomination requirements, and assessment procedures. Jimmy Alexander’s stated affiliation and reported scholarly indicators may provide background information, but they do not establish eligibility or selection. A robust nomination should include verified publications, a clear account of individual contributions, supporting documentation, and evidence aligned with the award’s stated criteria. [1]

 Conclusion

The available information identifies Jimmy Alexander with MGM College of Pharmacy, Kannur, Kerala, and lists medicinal chemistry as the subject area. Reported citation metrics offer an initial reference point, but a reliable academic assessment requires verified publications and documented contributions. Award suitability should be determined through the official criteria and independent evidence. This profile therefore provides a structured overview without implying confirmed award recognition. [1]

References

  1. Google Scholar. (n.d.). Jimmy Alexander: Google Scholar profile. The profile link was supplied for this article; citation indicators and bibliographic records should be checked against the live profile.
    https://scholar.google.com/citations?user=7Z3vnIwAAAAJ&hl=en
  2. Indian Scientist. (n.d.). Indian Scientist Awards website. The organizer’s website is the starting point for checking current award categories, eligibility conditions, nomination procedures, and announcements. No specific award result is claimed in this article.
    https://indianscientist.in/

Vijay Mohan | Cancer Drug Discovery | Innovative Research Award

Posted-on by Indian Scientist Awards

Innovative Research Award

Vijay Mohan
Galgotias University

Vijay Mohan
Affiliation Galgotias University
Country India
Scopus ID 57472028500
Documents 2
Citations 23
h-index 2
Subject Area Cancer Drug Discovery
Event Indian Scientist Awards

Vijay Mohan is associated with Galgotias University, India, and is engaged in research related to Cancer Drug Discovery. His academic work focuses on scientific approaches that contribute to understanding therapeutic targets, drug development strategies, and translational biomedical research. Through scholarly publications and research dissemination, he has contributed to the growing body of knowledge supporting advancements in oncology and pharmaceutical sciences.[1]

Abstract

The Innovative Research Award recognizes researchers who demonstrate originality, scientific rigor, and meaningful scholarly contributions. Vijay Mohan’s research profile reflects engagement in Cancer Drug Discovery, a field that integrates biomedical science, medicinal chemistry, pharmacology, and computational approaches to identify and develop effective therapeutic interventions. His publication and citation record illustrates active participation in scientific inquiry and knowledge dissemination within the biomedical research community.[1][2]

Keywords

Cancer Drug Discovery; Oncology Research; Therapeutic Development; Pharmaceutical Sciences; Biomedical Innovation; Precision Medicine; Drug Design; Translational Research; Cancer Therapeutics; Innovative Research.

Introduction

Cancer remains one of the most significant global health challenges, creating an ongoing need for innovative therapeutic strategies and improved treatment approaches. Cancer Drug Discovery encompasses multidisciplinary efforts directed toward identifying novel compounds, therapeutic targets, and personalized treatment methodologies. Researchers working in this field contribute to advancements that support both fundamental scientific understanding and practical clinical applications.[2]

Research Profile

Vijay Mohan is affiliated with Galgotias University and has established a documented research presence within Cancer Drug Discovery. According to available scholarly indicators, his profile includes two indexed publications, twenty-three citations, and an h-index of two. These metrics reflect research visibility and participation in academic discourse within biomedical and pharmaceutical research domains.[1]

  • Research focus on cancer therapeutics and drug discovery.
  • Interest in translational and biomedical research methodologies.
  • Contribution to scientific publication and scholarly communication.
  • Participation in interdisciplinary healthcare research initiatives.

Research Contributions

Research contributions within Cancer Drug Discovery support the identification of novel therapeutic compounds and improve understanding of disease mechanisms. Scientific efforts in this area often involve target validation, medicinal chemistry, molecular biology, and pharmacological evaluation. Such contributions assist in the development of more effective and personalized treatment strategies for cancer patients.[2]

  • Investigation of therapeutic targets relevant to oncology.
  • Support for innovative approaches to drug development.
  • Contribution to evidence-based biomedical research.
  • Participation in scientific initiatives focused on healthcare advancement.

Publications

The publication record associated with Vijay Mohan reflects scholarly engagement within biomedical and pharmaceutical research. Publications serve as an important mechanism for communicating scientific findings, facilitating peer review, and supporting future investigations in cancer-related research fields.[1]

  1. Research publications related to cancer therapeutics.
  2. Scientific articles supporting drug discovery initiatives.
  3. Peer-reviewed contributions to biomedical literature.
  4. Collaborative research outputs within healthcare sciences.

Research Impact

Research impact may be evaluated through scholarly publications, citations, academic visibility, and contribution to scientific advancement. The citation record associated with Vijay Mohan indicates engagement with the research community and demonstrates that his work has contributed to ongoing scientific discussions within cancer-related biomedical research.[1]

Award Suitability

The Innovative Research Award recognizes researchers whose scholarly activities demonstrate originality, scientific relevance, and meaningful academic contribution. Based on available research indicators and documented scientific engagement, Vijay Mohan exhibits characteristics aligned with innovative research practice through his involvement in Cancer Drug Discovery and biomedical research initiatives. These attributes support consideration within research recognition and excellence programs.[1]

Conclusion

Vijay Mohan’s research profile reflects continued engagement in Cancer Drug Discovery and biomedical research. Through scholarly publication, scientific communication, and contributions to oncology-related investigations, he participates in efforts aimed at advancing therapeutic innovation and healthcare outcomes. The Innovative Research Award provides an appropriate framework for recognizing such scholarly contributions and encouraging continued research excellence.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Vijay Mohan, Author ID 57472028500. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57472028500
  2. Role of Transcription Factor BEND3 and Its Potential Effect on Cancer Progression
    https://www.mdpi.com/2072-6694/15/14/3685

Meghraj Vivekanand Suryawanshi | Pharmaceutics | Innovative Research Award

Posted-on by Indian Scientist Awards

Innovative Research Award

Meghraj Vivekanand Suryawanshi
Affiliation Savitribai Phule Pune University
Country India
Scopus ID 58037948200
Documents 48
Citations 104
h-index 5
Subject Area Pharmaceutics
Event Indian Scientist Awards
ORCID 0000-0003-3958-2813

Meghraj Vivekanand Suryawanshi

Savitribai Phule Pune University, India

Meghraj Vivekanand Suryawanshi has contributed to the field of Pharmaceutics through research activities reflected in indexed publications, citations, and measurable scholarly impact. His academic profile demonstrates sustained engagement in pharmaceutical sciences and related research domains, supporting scientific knowledge dissemination and interdisciplinary collaboration.[1][2]

Abstract

This article presents an academic overview of Meghraj Vivekanand Suryawanshi and his scholarly contributions within the field of Pharmaceutics. The profile highlights publication activity, citation performance, research engagement, and academic impact indicators documented through internationally recognized indexing platforms. The assessment considers research productivity, contribution to pharmaceutical sciences, and relevance to innovation-oriented scientific recognition programs.[1]

Keywords

Pharmaceutics, Drug Delivery Systems, Pharmaceutical Research, Scientific Innovation, Research Impact, Scholarly Publications, Citation Analysis, Academic Recognition, Pharmaceutical Sciences, Innovative Research Award.

Introduction

Research in pharmaceutics plays a fundamental role in improving therapeutic outcomes, formulation technologies, drug delivery mechanisms, and pharmaceutical manufacturing processes. Academic researchers contribute to the advancement of healthcare through experimental investigations, translational research, and dissemination of scientific findings. Meghraj Vivekanand Suryawanshi’s scholarly profile reflects active participation in these efforts through publication and citation records indexed in major academic databases.[1]

Research Profile

Meghraj Vivekanand Suryawanshi is affiliated with Savitribai Phule Pune University, a recognized institution engaged in higher education and scientific research. His documented scholarly profile includes research publications indexed in Scopus, demonstrating contributions to pharmaceutical sciences and related disciplines.[1]

  • Institutional Affiliation: Savitribai Phule Pune University.
  • Country of Research Activity: India.
  • Scopus Indexed Documents: 48.
  • Citation Count: 104.
  • h-index: 5.
  • Primary Subject Area: Pharmaceutics.

Research Contributions

The research contributions associated with this profile encompass pharmaceutical formulation studies, drug delivery approaches, evaluation methodologies, and related pharmaceutical investigations. Such work supports the broader objective of improving therapeutic effectiveness and scientific understanding within the pharmaceutical sector.[3]

  • Development and evaluation of pharmaceutical formulations.
  • Investigation of drug delivery technologies.
  • Research supporting pharmaceutical quality and efficacy assessment.
  • Contribution to peer-reviewed scientific literature.
  • Participation in collaborative and interdisciplinary research activities.

Publications

Publication activity serves as an important indicator of academic productivity. The available bibliometric profile demonstrates a record of peer-reviewed outputs that contribute to knowledge generation in pharmaceutical sciences and allied research areas.[1]

  1. Research articles indexed in international scientific databases.
  2. Studies related to pharmaceutical formulation and evaluation.
  3. Scientific communications supporting evidence-based pharmaceutical development.
  4. Collaborative publications contributing to interdisciplinary knowledge exchange.

Research Impact

Research impact may be evaluated through bibliometric indicators including publication volume, citation performance, and h-index metrics. With 48 indexed documents, 104 citations, and an h-index of 5, the profile demonstrates measurable scholarly visibility within the academic community.[1]

  • Evidence of sustained scholarly publication activity.
  • Research findings referenced by other investigators.
  • Contribution to scientific discourse within pharmaceutics.
  • Academic visibility reflected through citation metrics.

Award Suitability

The Innovative Research Award recognizes researchers whose scholarly activities contribute to scientific advancement and innovation. Based on the documented research profile, publication record, citation indicators, and engagement in pharmaceutical sciences, Meghraj Vivekanand Suryawanshi demonstrates attributes commonly associated with academic recognition programs emphasizing innovation, research productivity, and knowledge dissemination.[1][2]

Conclusion

Meghraj Vivekanand Suryawanshi’s academic profile reflects sustained participation in pharmaceutical research and scholarly publication. Through documented contributions in Pharmaceutics, indexed publications, citation performance, and measurable research indicators, the profile represents ongoing engagement with scientific inquiry and evidence-based knowledge development. These characteristics align with the objectives of professional research recognition initiatives such as the Innovative Research Award.[1]

References

  1. Scopus author details: Meghraj Vivekanand Suryawanshi, Author ID 58037948200. Scopus.https://www.scopus.com/authid/detail.uri?authorId=58037948200
  2. Medicinal and Nutritional Importance of Hypericum perforatum in Human Health.https://link.springer.com/chapter/10.1007/978-981-95-3620-7_13
  3. Neuroprotective efficacy of Nyctanthes arbor-tristis in a rotenone-induced rat model of Parkinson’s disease

    https://www.sciencedirect.com/science/article/abs/pii/S0378874126006781?via%3Dihub

Jon Jyoti Sahariah | Medicinal Chemistry | Research Excellence Award

Posted-on by Indian Scientist Awards

Research Excellence Award

Jon Jyoti Sahariah
Dibrugarh University, India

Jon Jyoti Sahariah
Affiliation Dibrugarh University
Country India
Scopus ID 57225212218
Documents 19
Citations 125
h-index 6
Subject Area Medicinal Chemistry
Event Indian Scientist Awards

Jon Jyoti Sahariah is an academic researcher affiliated with Dibrugarh University, India, whose scholarly activities are associated with medicinal chemistry, pharmaceutical sciences, drug delivery systems, and therapeutic development. His published research contributions demonstrate engagement with contemporary challenges in drug discovery, targeted therapeutics, and biomedical innovation. Through peer-reviewed publications, citation impact, and interdisciplinary collaborations, he has contributed to advancing scientific understanding within medicinal chemistry and related biomedical disciplines.[1]

Abstract

This article presents an academic overview of Jon Jyoti Sahariah and his scholarly contributions within medicinal chemistry and pharmaceutical research. The profile summarizes research interests, publication records, citation metrics, scientific influence, and relevance to recognition through the Research Excellence Award. The assessment is based on publicly available scholarly indicators and peer-reviewed academic outputs.[1]

Keywords

Medicinal Chemistry, Drug Discovery, Pharmaceutical Sciences, Targeted Drug Delivery, Cancer Therapeutics, Liposomal Formulations, Biomedical Research, Therapeutic Development, Scientific Publications, Research Excellence.

Introduction

Medicinal chemistry plays a critical role in the development of novel therapeutic agents and advanced healthcare solutions. Researchers working in this field contribute to the identification, optimization, and evaluation of biologically active compounds for the prevention and treatment of diseases. Jon Jyoti Sahariah’s academic activities align with these objectives through investigations focused on pharmaceutical formulations, drug delivery systems, and therapeutic innovations. His work reflects interdisciplinary collaboration across chemistry, pharmacy, and biomedical sciences.[2]

Research Profile

The scholarly profile of Jon Jyoti Sahariah demonstrates sustained participation in scientific research and publication. According to available bibliometric indicators, his research output includes nineteen indexed documents, 125 citations, and an h-index of six. These metrics indicate measurable academic visibility and engagement within the scientific community. His publications encompass medicinal chemistry, drug delivery technologies, cancer therapeutics, and pharmaceutical innovations.[1]

  • Affiliation with Dibrugarh University, India.
  • Research specialization in medicinal chemistry and pharmaceutical sciences.
  • Indexed publications in peer-reviewed journals.
  • Interdisciplinary collaboration involving drug discovery and therapeutic development.

Research Contributions

Jon Jyoti Sahariah has contributed to studies involving natural bioactive compounds, targeted cancer therapies, liposomal drug delivery systems, and pharmaceutical technologies. Several publications examine mechanisms for improving therapeutic efficacy while reducing adverse effects associated with conventional treatments. Research efforts in these domains contribute to ongoing developments in precision medicine and translational pharmaceutical science.[3]

  • Investigation of natural compounds with therapeutic potential.
  • Research on advanced liposomal drug delivery systems.
  • Contributions to targeted cancer therapy methodologies.
  • Participation in multidisciplinary biomedical research projects.

Publications

Selected scholarly works associated with Jon Jyoti Sahariah include publications addressing cancer chemotherapy, liposomal drug delivery, and medicinal chemistry innovations. Representative studies include highly cited articles focusing on natural bioactive compounds and targeted therapeutic approaches.[3]

  1. Cancer Chemotherapy via Natural Bioactive Compounds.
  2. Advancing Liposomal Doxorubicin for Targeted Cancer Therapy.
  3. Research involving pharmaceutical formulation and drug delivery technologies.
  4. Studies related to medicinal chemistry and therapeutic development.

Research Impact

Research impact can be assessed through publication output, citation frequency, collaborative scholarship, and relevance to scientific advancement. The citation record associated with Jon Jyoti Sahariah indicates that his work has been referenced by researchers in related fields, reflecting scholarly engagement and knowledge dissemination. Contributions to pharmaceutical sciences and medicinal chemistry support ongoing scientific dialogue regarding improved therapeutic interventions.[1]

Award Suitability

The Research Excellence Award recognizes researchers demonstrating meaningful scholarly contributions, scientific productivity, and academic influence. Based on available publication records, citation metrics, and participation in medicinal chemistry research, Jon Jyoti Sahariah exhibits characteristics consistent with the objectives of academic recognition programs. His work contributes to knowledge advancement in pharmaceutical and biomedical sciences while supporting innovation in therapeutic research.[1][4]

Conclusion

Jon Jyoti Sahariah has established a scholarly profile characterized by contributions to medicinal chemistry, drug delivery systems, and pharmaceutical sciences. Through peer-reviewed publications, citation impact, and collaborative scientific efforts, he has participated in research addressing significant healthcare and therapeutic challenges. His academic record supports consideration for professional recognition through the Research Excellence Award and reflects ongoing engagement with scientific advancement.[1]

References

  1. Scopus author details: Jon Jyoti Sahariah, Author ID 57225212218. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57225212218
  2. Cancer chemotherapy via natural bioactive compounds. https://www.benthamdirect.com/content/journals/cddt/10.2174/1570163819666220331095744
  3. From bench to bedside: Advancing liposomal doxorubicin for targeted cancer therapy. https://www.sciencedirect.com/science/article/pii/S2666845925000601
  4. Revolutionizing patient care: 3D printing for customized medical devices and therapeutics. https://link.springer.com/article/10.1007/s44174-025-00324-2

Mr. Akash Vikal | Nanotechnology and Advanced Materials | Innovative Research Award

Posted-on by Indian Scientist Awards

Mr. Akash Vikal | Nanotechnology and Advanced Materials | Innovative Research Award

IFTM University, Moradabad, India

Akash Vikal is an emerging pharmaceutical researcher specializing in pharmaceutics, nanomedicine, advanced drug delivery systems, and cancer therapeutics. His academic and research contributions primarily focus on the development of innovative formulation strategies designed to improve therapeutic efficacy, targeted delivery, and patient outcomes. Through extensive research in liposomal formulations, nanocarriers, gene delivery systems, and ocular therapeutics, he has established himself as a promising young contributor to modern pharmaceutical sciences.His research portfolio reflects interdisciplinary expertise integrating pharmaceutical technology, nanotechnology, oncology, ophthalmic therapeutics, and translational medicine. With numerous peer-reviewed publications, book chapters, and scientific presentations, he has actively contributed to advancing pharmaceutical innovation and drug delivery research.

Professional Profile 

Education

Akash Vikal completed a Bachelor of Pharmacy (B.Pharm.) from Shri Gopichand College of Pharmacy with strong academic performance. He further pursued a Master of Pharmacy (M.Pharm.) in Pharmaceutics from ISF College of Pharmacy, where he specialized in advanced pharmaceutical formulation and drug delivery systems. His postgraduate research focused on the “Development and Characterization of Ferulic Acid and Docetaxel Loaded Liposomes Against Breast Cancer” under the guidance of Balak Das Kurmi.

Professional Experience

During his academic journey, Akash Vikal gained industrial exposure through internship training at HIS Pharmaceuticals Pvt. Ltd., where he developed practical knowledge related to pharmaceutical manufacturing and formulation processes. He has also actively contributed to scientific communication and peer-review activities, including reviewing submissions for reputed journals such as Dovepress journals Clinical Ophthalmology and Eye and Brain. In addition, he delivered an academic webinar on scientific writing and publication strategies for researchers and healthcare professionals.

Research Interest

He has contributed extensively to pharmaceutical and biomedical research through numerous publications in reputed international journals. His research covers areas such as metal-organic frameworks in drug delivery, PROTAC-based cancer therapy, nanoparticle-mediated antimicrobial strategies, CRISPR-assisted nanotechnology, nanocarrier systems for ocular therapeutics, and phytoconstituent-based anticancer therapies. Several of his works have been published in recognized journals including Applied Materials Today, Drug Delivery and Translational Research, AAPS PharmSciTech, Current Pharmaceutical Design, and Experimental Eye Research.

Award and Honor

Akash Vikal has received recognition for his academic and scientific contributions through participation in national and international conferences, workshops, and faculty development programs. He earned a Certificate of Excellence in Peer Reviewing for his contribution to academic quality enhancement. His involvement in intellectual property awareness programs, pharmaceutical research conferences, and specialized training workshops reflects his commitment to continuous professional development and scientific advancement.

Conclusion

Mebratu Tafesse Teferi demonstrates strong potential for the Best Researcher Award. His substantial academic qualifications, leadership experience, and dedication to educational research are commendable. His publications reflect significant contributions to Ethiopian education and leadership studies, making him a valuable candidate for the award. To further enhance his candidacy, Mebratu could focus on broadening his research scope, fostering international collaborations, and increasing his publication reach in globally recognized journals.

Publications Top Noted

  • Next-generation gene editing strategies in cancer: Integrating CRISPR, PROTACs, and advanced molecular technologies
    Authors: Akash Vikal, Rashmi Maurya, Pradeep Kumar, Navneet Verma, Arun Kumar Mishra
    Year: 2026
  • Liposomal Paclitaxel in Breast Cancer Therapy: Advances, Clinical Insights, and Future Perspectives
    Authors: Akash Vikal, Rashmi Maurya, Navneet Verma, Arun Kumar Mishra
    Year: 2026
  • A Mini-Review on Unlocking Cognitive Enhancement: An Innovative Strategy for Optimal Brain Functions
    Authors: Akash Vikal, Rashmi Maurya, Brij Bihari Patel, Preeti Patel, Manish Kumar, Balak Das Kurmi
    Year: 2025
  • Andrographis paniculata in Fatty Liver Disease: Mechanisms, Nanocarrier Approaches, and Therapeutic Potential
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi
    Year: 2025
  • Development of Mucopenetrating Pegylated Liposomes Functionalized with Sodium Taurocholate for Enhanced Oral Insulin Delivery
    Authors: Akash Vikal, Rashmi Maurya, Balak Das Kurmi, S. Jindal, R. K. Narang
    Year: 2025
  • From Resistance to Response: Metallic Nanoparticles as Game Changers in Triple Negative Breast Cancer Therapy
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, R. K. Narang, Balak Das Kurmi
    Year: 2025
  • Lutein as a Liver Guardian: Insights into its Hepatoprotective Mechanisms, Bioavailability, and Emerging Therapeutic Roles
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi
    Year: 2025
  • Nanoemulsion Technology in Oral Drug Delivery: A Path to Enhanced Solubility and Bioavailability
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi
    Year: 2025
  • Role of dePEGylation in Vesicular Carriers-Mediated Stimuli-Responsive Drug Delivery to Tumors
    Authors: Akash Vikal, Rashmi Maurya, Abhinav Vashishat, Taqdir Singh, Satyam Khare, Preeti Patel, Balak Das Kurmi
    Year: 2025

 

Gnana Ruba Priya Muthaiya | Medicinal Chemistry | Best Researcher Award

Posted-on by Indian Scientist Awards

Dr. Gnana Ruba Priya Muthaiya | Medicinal Chemistry | Best Researcher Award

Dayananda Sagar University, India

Dr. Gnana Ruba Priya Muthaiya is an accomplished pharmaceutical chemist and academician with advanced expertise in medicinal chemistry and drug design. Holding doctoral and postgraduate qualifications in pharmaceutical sciences, she has extensive experience in teaching, research, and mentoring across pharmacy disciplines. Her research focuses on computer-aided drug discovery, green synthesis, and anticancer therapeutics. With numerous peer-reviewed publications, patents, and scientific contributions, she has earned recognition for research excellence. Her work reflects a strong commitment to innovative drug development and impactful advancements in healthcare science.

Citation Metrics (Scopus)

70
50
30
10
0

Citations
60

Documents
1

h-index
1

Citations

Documents

h-index

Featured Publications


Artificial intelligence in screening: Models versus experiments


– Drug Discovery Today (Cited by 93 · Year: 2022)

Vidhya Bhusari | Pharmaceutical Sciences | Women Researcher Award

Posted-on by Indian Scientist Awards

Dr. Vidhya Bhusari | Pharmaceutical Sciences | Women Researcher Award

Chitkara College of Pharmacy, Chitkara University, India

Dr. Vidhya Kishore Bhusari is an accomplished pharmaceutical chemist with advanced training in pharmaceutical chemistry and extensive experience spanning academia and the pharmaceutical industry. She has contributed significantly to analytical method development, drug regulatory affairs, and quality assurance. Her research focuses on green analytical chemistry, HPTLC, HPLC, LC-MS techniques, stability-indicating methods, and QbD approaches. She is a recognized award recipient with impactful publications, patents, and scholarly books, contributing meaningfully to pharmaceutical education and research advancement.

Research Metrics (Scopus)

200
150
100
50
10
5
0

Citations
198

Documents
40

h-index
9

Citations

Documents

h-index

Featured Publications